Parkinson’s disease is a chronic progressive movement disorder, and its treatment includes medication, brain pacemaker surgery and rehabilitation. Among them, brain pacemaker surgery can effectively treat and relieve the symptoms of Parkinson’s disease such as tremor, rigidity and motor retardation, and many Parkinson’s patients are happy to choose brain pacemaker surgery for Parkinson’s. Regarding the treatment of Parkinson’s disease, Professor Wang of the Department of Neurosurgery said, “Early symptoms of Parkinson’s disease develop relatively quickly, faster than the development of the disease after the middle stage. There are differences in treatment modalities for different developmental stages of Parkinson’s disease.” 1, drug treatment should be timely Early stage is mainly based on clear diagnosis. Parkinson’s disease early if the symptoms are not heavy, does not affect the work and life, you can temporarily observe, do not take drugs, in order to try to postpone the time to take drugs, take to strengthen the functional exercise. Professor Wang explained that if high doses of anti-Parkinson’s disease drugs are given early, although satisfactory treatment results can be achieved, but it is likely to accelerate the progress of the disease, so that the side effects of drug therapy appear early. However, if the symptoms are obvious, the medication should be taken in time to control the symptoms. Therefore, it is wrong to take medication too early or too late. 2. Treatment varies by age There are several reasons to think that age is an important factor in deciding when and how to start treatment. First, although symptoms may be more severe in younger patients, younger patients usually have a more benign disease process and better intellectual status than older patients. In addition, younger patients are often expected to be treated for more than 20 years, so for long-term treatment purposes, the first consideration when choosing medication is to try to avoid the adverse effects of long-term levodopa application and to enhance neuroprotective treatment to avoid disease progression. 3. The dose varies from person to person Patients should pay attention to long-term medication and take it regularly every day, and not to stop it suddenly on their own. Since levodopa is not a drug for treating the cause of the disease, but an alternative treatment to improve symptoms, and may bring side effects, it is recommended that the lower the maintenance dose, the better, under the premise of minimizing side effects and maximizing the patient’s ability to live. In short, the need to take drugs to achieve “a long stream, not to seek full effect”, that is, the dose as small as possible, long-term regular intake, to achieve about 80% of the effect can be. Some patients choose the most effective dopamine preparations at the beginning of the medication, the effect of such drugs is obvious, but may make the side effects appear early. Therefore, for younger early patients, they should choose dopamine agonists and other drugs, which are less effective and have obvious side effects, but can delay the appearance of drug side effects; for older early patients, they can apply dope-like drugs. If tremor symptoms are more pronounced, for younger patients, Antan can be administered, but for older patients, Antan may be less appropriate; Antan is cognitively impairing and can lead to hallucinations, so levodopa preparations can be used. The principle of drug selection is to choose simple and effective drugs, and not to use second- or third-line drugs if you can use first-line drugs, and not to blindly pursue new drugs. At present, almost all new drugs are adjuvant to levodopa preparations, which means that a new drug cannot be used alone to control Parkinson’s disease symptoms, and levodopa is still the gold standard for the treatment of Parkinson’s disease